{"id":"https://openalex.org/W1967508221","doi":"https://doi.org/10.1097/00008390-200306000-00014","title":"Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma","display_name":"Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma","publication_year":2003,"publication_date":"2003-05-17","ids":{"openalex":"https://openalex.org/W1967508221","doi":"https://doi.org/10.1097/00008390-200306000-00014","mag":"1967508221","pmid":"https://pubmed.ncbi.nlm.nih.gov/12777988"},"language":"en","primary_location":{"id":"doi:10.1097/00008390-200306000-00014","doi":"https://doi.org/10.1097/00008390-200306000-00014","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008390-200306000-00014","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060495866","display_name":"Steven J O'Day","orcid":"https://orcid.org/0009-0005-5345-5417","observed_orcids":["https://orcid.org/0009-0005-5345-5417"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Steven J O'Day","raw_affiliation_strings":["John Wayne Cancer Institute, Santa Monica, California 90404, USA. odays@jwci.org","John Wayne Cancer Institute, Santa Monica, California, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Wayne Cancer Institute, Santa Monica, California 90404, USA. odays@jwci.org","institution_ids":[]},{"raw_affiliation_string":"John Wayne Cancer Institute, Santa Monica, California, USA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061683749","display_name":"Sanjiv S. Agarwala","orcid":"https://orcid.org/0000-0001-9416-8768","observed_orcids":["https://orcid.org/0000-0001-9416-8768"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjiv S Agarwala","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062137466","display_name":"Peter L. J. Naredi","orcid":"https://orcid.org/0000-0002-5652-0422","observed_orcids":["https://orcid.org/0000-0002-5652-0422"]},"institutions":[{"id":"https://openalex.org/I90267481","display_name":"Ume\u00e5 University","ror":"https://ror.org/05kb8h459","country_code":"SE","type":"education","lineage":["https://openalex.org/I90267481"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Peter Naredi","raw_affiliation_strings":["University of Umea, Umea, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Umea, Umea, Sweden","institution_ids":["https://openalex.org/I90267481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010789887","display_name":"Carrie L Kass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carrie L Kass","raw_affiliation_strings":["Maxim Pharmaceuticals, San Diego, California, USA and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maxim Pharmaceuticals, San Diego, California, USA and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110435388","display_name":"Kurt R. Gehlsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kurt R Gehlsen","raw_affiliation_strings":["Maxim Pharmaceuticals, San Diego, California, USA and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maxim Pharmaceuticals, San Diego, California, USA and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Glaspy","raw_affiliation_strings":["Bowyer Oncology Center, UCLA, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bowyer Oncology Center, UCLA, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060495866"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8969,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.72297732,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"13","issue":"3","first_page":"307","last_page":"311"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histamine-dihydrochloride","display_name":"histamine dihydrochloride","score":0.9660000205039978},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.781000018119812},{"id":"https://openalex.org/keywords/subcutaneous-interleukin-2","display_name":"subcutaneous interleukin-2","score":0.843999981880188},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7160000205039978},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7239999771118164},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.8619999885559082},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5540000200271606},{"id":"https://openalex.org/keywords/drug-interruption","display_name":"drug interruption","score":0.3070000112056732},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5199999809265137},{"id":"https://openalex.org/keywords/survival-benefit","display_name":"survival benefit","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8993079662322998},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7125258445739746},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.7116596698760986},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6298512816429138},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6224321722984314},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.540303111076355},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49468037486076355},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4892287254333496},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.439535915851593},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3324187695980072},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001247","descriptor_name":"Asthenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006632","descriptor_name":"Histamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014664","descriptor_name":"Vasodilation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023341","descriptor_name":"Chills","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00008390-200306000-00014","doi":"https://doi.org/10.1097/00008390-200306000-00014","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008390-200306000-00014","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:12777988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12777988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1769520442","https://openalex.org/W1903830321","https://openalex.org/W1919811975","https://openalex.org/W1975284023","https://openalex.org/W1991478818","https://openalex.org/W2012951244","https://openalex.org/W2018979262","https://openalex.org/W2037233630","https://openalex.org/W2105255021","https://openalex.org/W2143323652","https://openalex.org/W2300901264","https://openalex.org/W2331882193"],"related_works":["https://openalex.org/W2143323652","https://openalex.org/W2328995265","https://openalex.org/W2127408434","https://openalex.org/W1764925035","https://openalex.org/W2040469800","https://openalex.org/W2066871490","https://openalex.org/W2132773956","https://openalex.org/W2061500381","https://openalex.org/W2018046489","https://openalex.org/W2076536262"],"abstract_inverted_index":{"Intravenous":[0],"high":[1],"dose":[2,27,194],"bolus":[3],"therapy":[4],"with":[5,10,40,76,90,137],"interleukin-2":[6],"(IL2)":[7],"is":[8],"associated":[9],"low":[11,201],"overall":[12],"response":[13],"rates":[14],"(15%)":[15],"and":[16,21,56,144,202],"significant":[17],"toxicity.":[18],"Phase":[19],"II":[20],"III":[22,68],"trials":[23],"of":[24,30,59,62,132,157,161,175,191,209],"a":[25,53,71,186],"lower":[26],"subcutaneous":[28,179],"regimen":[29,181],"IL2":[31,180,213],"administered":[32],"alone":[33],"(n":[34,43],"=":[35,44],"152)":[36],"or":[37,128,164,196],"in":[38,74,79,114,120,185,188],"combination":[39],"histamine":[41,138,176,210],"dihydrochloride":[42],"239)":[45],"have":[46],"recently":[47],"been":[48],"completed.":[49],"This":[50],"article":[51],"describes":[52],"comprehensive":[54],"safety":[55],"toxicity":[57,106],"analysis":[58],"the":[60,80,100,115,155,159,170,178,189,207,212],"results":[61],"these":[63],"two":[64],"trials.":[65],"The":[66,130,173],"phase":[67],"trial":[69],"demonstrated":[70],"survival":[72],"benefit":[73],"patients":[75,84,151],"liver":[77],"metastases":[78],"histamine/IL2":[81],"arm.":[82],"Eligible":[83],"had":[85],"stage":[86],"IV":[87],"malignant":[88],"melanoma":[89],"at":[91],"least":[92],"one":[93],"measurable":[94],"lesion.":[95],"Toxicity":[96],"was":[97,167],"graded":[98],"using":[99],"National":[101],"Cancer":[102],"Institute":[103],"(NCI)":[104],"common":[105],"scale.":[107],"All":[108],"reported":[109],"adverse":[110],"events":[111],"were":[112,124,148,200,203],"included":[113],"analysis.":[116],"Almost":[117],"all":[118],"toxicities":[119,133,166],"each":[121],"treatment":[122,171],"group":[123],"NCI":[125],"grade":[126,162],"1":[127],"2.":[129],"incidence":[131,160,190],"expected":[134],"to":[135,177,211],"occur":[136],"treatment,":[139],"such":[140],"as":[141],"hypotension/vasodilation,":[142],"headache":[143],"injection":[145],"site":[146],"reaction,":[147],"higher":[149],"among":[150],"receiving":[152],"histamine.":[153],"With":[154],"exception":[156],"headache,":[158],"3":[163],"4":[165],"similar":[168],"across":[169],"groups.":[172],"addition":[174,208],"did":[182],"not":[183,204],"result":[184],"difference":[187],"drug":[192],"interruption,":[193],"modification":[195],"discontinuation.":[197],"Study-related":[198],"deaths":[199],"impacted":[205],"by":[206],"regimen.":[214]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}